Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 3
2006 5
2007 4
2008 8
2009 4
2010 11
2011 10
2012 5
2013 8
2014 5
2015 9
2016 5
2017 10
2018 6
2019 5
2020 5
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.
Müller S, Bexte T, Gebel V, Kalensee F, Stolzenberg E, Hartmann J, Koehl U, Schambach A, Wels WS, Modlich U, Ullrich E. Müller S, et al. Among authors: koehl u. Front Immunol. 2020 Jan 24;10:3123. doi: 10.3389/fimmu.2019.03123. eCollection 2019. Front Immunol. 2020. PMID: 32117200 Free PMC article.
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
Klöß S, Oberschmidt O, Morgan M, Dahlke J, Arseniev L, Huppert V, Granzin M, Gardlowski T, Matthies N, Soltenborn S, Schambach A, Koehl U. Klöß S, et al. Among authors: koehl u. Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15. Hum Gene Ther. 2017. PMID: 28810809
Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.
Oberschmidt O, Morgan M, Huppert V, Kessler J, Gardlowski T, Matthies N, Aleksandrova K, Arseniev L, Schambach A, Koehl U, Kloess S. Oberschmidt O, et al. Among authors: koehl u. Hum Gene Ther Methods. 2019 Jun;30(3):102-120. doi: 10.1089/hgtb.2019.039. Epub 2019 May 16. Hum Gene Ther Methods. 2019. PMID: 30997855 Free PMC article.
Harnessing NK Cell Checkpoint-Modulating Immunotherapies.
Chauhan SKS, Koehl U, Kloess S. Chauhan SKS, et al. Among authors: koehl u. Cancers (Basel). 2020 Jul 6;12(7):1807. doi: 10.3390/cancers12071807. Cancers (Basel). 2020. PMID: 32640575 Free PMC article. Review.
Biological Properties of Cells Other Than HSCs.
Bondanza A, Koehl U, Hoffmann A, Toubert A. Bondanza A, et al. Among authors: koehl u. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 8. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 8. PMID: 32091770 Free Books & Documents. Review.
CAR-Expressing Natural Killer Cells for Cancer Retargeting.
Kloess S, Kretschmer A, Stahl L, Fricke S, Koehl U. Kloess S, et al. Among authors: koehl u. Transfus Med Hemother. 2019 Feb;46(1):4-13. doi: 10.1159/000495771. Epub 2019 Feb 5. Transfus Med Hemother. 2019. PMID: 31244577 Free PMC article. Review.
Cultivated anti-Aspergillus T(H)1 cells.
Lehrnbecher T, Beck O, Koehl U, Tramsen L. Lehrnbecher T, et al. Among authors: koehl u. Med Mycol. 2009;47 Suppl 1:S170-4. doi: 10.1080/13693780802169120. Epub 2008 Jun 10. Med Mycol. 2009. PMID: 18651313 Review.
94 results